Philips launches foetal-maternal monitors in EU, Africa and Middle East:
This article was originally published in Clinica
Philips Medical Systems has launched two new foetal-maternal ultrasound monitors across a number of European, African and Middle Eastern countries. Both the Avalon FM40 antepartum (pre-birth) and FM50 intrapartum (during labour) monitors feature a built-in colour monitor, and an external display with touch-screen capability that can be mounted in a different room to the patient. This allows the doctor to interact with the monitor even when they are away from the patient's bedside. Both monitors can measure maternal blood pressure, SpO2, maternal and foetal ECG and maternal heart rate. The systems can monitor the mother and up to three babies simultaneously. In addition, the transducers on both devices are constructed with a soft material to increase patient comfort, said the firm.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.